Two ASX 100 stocks of potential growth companies are indicating reversal after brief retracements. This could be another opportunity to invest in these high growth stocks.
Pro Medicus Limited (ASX: PME)
Pro Medicus Limited (ASX: PME) has recently secured multiple significant contracts that strengthen its position in the global health imaging market. On December 30, 2024, the company announced a $15M, 5-year deal with Duke University Health System. This contract, which builds on an existing 2019 agreement, involves the addition of Visage 7 Open Archive and the migration of Duke’s current on-premise system to the cloud. This deal is part of PME's strategy to expand into North American academic institutions, leveraging a transaction-based licensing model with potential upside.
Earlier in December, on the 23rd, Pro Medicus Limited signed a major $30M, 7-year contract with Duly Health and Care (DHC), a leading Midwest U.S. healthcare provider. The contract involves a complete transition to PME’s cloud-based Visage 7 platform, replacing DHC’s legacy PACS and vendor-neutral archive systems. It includes Visage 7 Viewer, Open Archive, and Workflow modules. The deal aligns with PME’s strategy to penetrate the private radiology and outpatient markets, where demand for cloud-based solutions is growing.
In November 2024, Pro Medicus Limited, one of the growing companies to invest in, also announced its largest contract to date: a $330M, 10-year deal with Trinity Health, one of the largest U.S. healthcare systems. This contract includes the full suite of Visage 7 products and will replace multiple legacy PACS across Trinity’s nationwide network. With a broad geographic footprint and a large number of radiologists and clinicians, this deal underscores the growing adoption of PME’s cloud-based solutions across integrated delivery networks (IDNs). Additionally, PME secured a $24M, 5-year contract with NYU Langone Health to upgrade its existing Visage 7 Viewer system by adding the Visage 7 Open Archive and transitioning to a fully cloud-based infrastructure. These wins reflect PME’s continued expansion in the North American market, particularly in academic and large healthcare systems.
WiseTech Global Limited (ASX: WTC)
WiseTech Global Limited (ASX: WTC) reported strong FY24 results, reaffirming its position as a leader in the global logistics technology sector. Total revenue grew 28% year-on-year (YoY) to $1,041.7 million, with organic growth contributing 15%. This performance was underpinned by the exceptional success of CargoWise, which recorded a 33% YoY revenue increase (19% organic) to $880.3 million. Recurring revenue rose 33% to $866.8 million, driven by Large Global Freight Forwarder (LGFF) rollouts, inflation-driven pricing adjustments, and ongoing customer expansion. Strategic acquisitions and strong execution further bolstered growth.
EBITDA increased 28% YoY to $495.6 million, delivering a margin of 48%, with the fourth quarter run rate reaching 50%. Underlying net profit after tax (NPAT) rose 15% to $283.5 million, while statutory NPAT grew 24% to $262.8 million. Free cash flow remained robust at $333.0 million, up 14% YoY, reflecting WiseTech’s operational efficiency and cash-generating capabilities. The company declared a final dividend of 9.2 cents per share, a 10% YoY increase, representing 20% of Underlying NPAT. CargoWise continues to expand its market presence, securing key LGFF customers such as Sinotrans, Nippon Express, and Yamato Transport, further solidifying its role as a mission-critical platform in the logistics industry. To maintain momentum, WiseTech plans to launch three major products in FY25: CargoWise Next, Container Transport Optimization, and ComplianceWise. These innovations are designed to enhance productivity, drive customer value, and reshape industry standards.
WiseTech is among the top growth stocks, having invested $368.2 million in research and development (R&D) in FY24, up 41% YoY and representing 35% of revenue. With 53% of R&D costs capitalized, the company continues to prioritize innovation while managing costs effectively. For FY25, WiseTech has provided strong guidance, forecasting revenue of $1,300–$1,350 million (25%–30% YoY growth) and EBITDA of $660–$700 million (33%–41% YoY growth), with margins expected to expand to 51%–52%. WiseTech’s disciplined financial management, scalable operating model, and focus on its 3P strategy—Product, Penetration, and Profitability—position it to capture significant market opportunities. With a robust innovation pipeline and over $500 million in liquidity, the company is well-equipped to deliver long-term shareholder value while executing its vision of becoming the operating system for global logistics.
Source: Company’s Report
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether it’s appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.